These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34507595)

  • 1. Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway.
    Zhou X; Jiang J; Guo S
    J Ovarian Res; 2021 Sep; 14(1):118. PubMed ID: 34507595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ-ACAP2 facilitates the progression of colorectal cancer through mediating miR-143-3p/FZD4 axis.
    Zhang G; Liu Z; Zhong J; Lin L
    Eur J Clin Invest; 2021 Dec; 51(12):e13607. PubMed ID: 34085707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.
    Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W
    Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M6A-mediated hsa_circ_0061179 inhibits DNA damage in ovarian cancer cells via miR-143-3p/TIMELESS.
    Zhang Y; Wu Y; Shi X; Ding H; Zhou Y; Chen H; Shen F; Chen Y; Zhou J; Zhou D; Wang J
    Mol Carcinog; 2024 Aug; 63(8):1542-1558. PubMed ID: 38751015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.
    Huang H; Yan L; Zhong J; Hong L; Zhang N; Luo X
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):275-286. PubMed ID: 35196944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis.
    Ma H; Qu S; Zhai Y; Yang X
    Cell Mol Biol Lett; 2022 Oct; 27(1):94. PubMed ID: 36273140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR‑124‑3p/EZH2 signaling pathway.
    Yang X; Wang J; Li H; Sun Y; Tong X
    Int J Mol Med; 2021 Feb; 47(2):668-676. PubMed ID: 33416105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer.
    Lv J; Zhang Y; Yang M; Qiao L; Wang H; Jiang H; Fu M; Qin J; Xu S
    Cancer Gene Ther; 2024 Jan; 31(1):108-118. PubMed ID: 38102461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
    Liu T; Yuan L; Zou X
    J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0001741 Suppresses Ovarian Cancer Cell Proliferations Through Adsorption of miR-188-5p and Promotion of FOXN2 Expression.
    Wang H; Liang C; Lin J; Dong Y; Wang Y; Xia L
    Mol Biotechnol; 2024 Jun; 66(6):1477-1483. PubMed ID: 37318741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer.
    Yin Y; Li J; Rong J; Zhang B; Wang X; Han H
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):261-274. PubMed ID: 35179434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184.
    Hou W; Zhang Y
    Pathol Res Pract; 2021 Jan; 217():153275. PubMed ID: 33285422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
    Xu YJ; Yu H; Liu GX
    J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0015326 Promotes the Proliferation, Invasion and Migration of Ovarian Cancer Through miR-127-3p/MYB.
    Zhang C; Liu W; Li F; Feng Y; Li Y; Wang J
    Cancer Manag Res; 2021; 13():2265-2277. PubMed ID: 33732019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hsa_circ_0020093 suppresses ovarian cancer progression by modulating LRPPRC activity and miR-107/LATS2 signaling.
    Sun Y; Chen X; Shi Y; Teng F; Dai C; Ge L; Xu J; Jia X
    Biol Direct; 2024 Aug; 19(1):69. PubMed ID: 39164777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
    Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
    Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.